- Home
- VRNA vs LAD Comparison
VRNA vs LAD Comparison
Compare VRNA & LAD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VRNA
- LAD
- Stock Information
- Founded
- VRNA 2005
- LAD 1946
- Country
- VRNA United Kingdom
- LAD United States
- Employees
- VRNA N/A
- LAD N/A
- Industry
- VRNA Biotechnology: Pharmaceutical Preparations
- LAD Retail-Auto Dealers and Gas Stations
- Sector
- VRNA Health Care
- LAD Consumer Discretionary
- Exchange
- VRNA Nasdaq
- LAD Nasdaq
- Market Cap
- VRNA 8.3B
- LAD 7.4B
- IPO Year
- VRNA 2017
- LAD 1996
- Fundamental
- Price
- VRNA $105.79
- LAD $338.93
- Analyst Decision
- VRNA Buy
- LAD Strong Buy
- Analyst Count
- VRNA 11
- LAD 13
- Target Price
- VRNA $114.10
- LAD $383.38
- AVG Volume (30 Days)
- VRNA 1.4M
- LAD 315.1K
- Earning Date
- VRNA 08-06-2025
- LAD 10-22-2025
- Dividend Yield
- VRNA N/A
- LAD 0.65%
- EPS Growth
- VRNA N/A
- LAD 8.81
- EPS
- VRNA N/A
- LAD 33.70
- Revenue
- VRNA $221,673,000.00
- LAD $37,155,800,000.00
- Revenue This Year
- VRNA $896.59
- LAD $4.45
- Revenue Next Year
- VRNA $77.56
- LAD $4.49
- P/E Ratio
- VRNA N/A
- LAD $10.09
- Revenue Growth
- VRNA N/A
- LAD 10.11
- 52 Week Low
- VRNA $24.50
- LAD $255.32
- 52 Week High
- VRNA $105.89
- LAD $405.68
- Technical
- Relative Strength Index (RSI)
- VRNA 68.01
- LAD 66.81
- Support Level
- VRNA $105.23
- LAD $302.50
- Resistance Level
- VRNA $105.81
- LAD $341.00
- Average True Range (ATR)
- VRNA 0.25
- LAD 7.82
- MACD
- VRNA -0.36
- LAD 5.32
- Stochastic Oscillator
- VRNA 87.88
- LAD 98.09
About VRNA Verona Pharma plc
Verona Pharma PLC is a clinical-stage biopharmaceutical company focused on developing and commercializing therapeutics for the treatment of respiratory diseases with unmet medical needs. The company is currently focusing on developing its Ensifentrine product candidate, which will treat chronic obstructive pulmonary disease (COPD), cystic fibrosis (CF), and other respiratory diseases, including asthma.
About LAD Lithia Motors Inc.
Lithia Motors is a retailer of new and used vehicles and related services. The company offers over 50 brands of vehicles at nearly 500 stores globally across the US, Canada, and UK. The company has expanded largely through the acquisition of dealerships in smaller regional markets but now seeks to grow in any part of the US and we expect more deals over time in the US and, at times, abroad. Annual revenue in 2024 was $36.2 billion and we see over $50 billion possible in a few years. The US was 78% of 2024 revenue and the UK second at 19%, due to the 2024 Pendragon acquisition. In 2024, new vehicle sales were about 49% of total revenue. Lithia was founded in 1946, went public in 1996, and is the largest US auto dealer. It is based in Medford, Oregon.